Tumor cells inhibit the activity and function of immune cells through various mechanisms, including the secretion of immunosuppressive factors (TGF‐β, IL‐10, etc.)and the up‐regulation of the expression of immune checkpoint molecules (PD‐1, CTLA‐4, etc.). This evidence concerns the gene RPL17 and neoplasm.